MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/iid3.70463

Медицинская библиотека · Immunity, inflammation and disease · 2026

Widespread SARS-CoV-2 Transmission Despite Limited Reported Cases and Clinical Disease: Exploring the Role of Pre-Existing Humoral Immunity to SARS-CoV-2 in Eastern Sierra Leone.

Samuels Robert J, Bond Nell G, Sumah Ibrahim, Grant Donald S, Kamara Mohamed S, Bazzano Lydia, Fernandez Camilo, Borrega Rodrigo, Chandra Sruti, Glezer Celia R, Schieffelin John S, Moon Troy D

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Since December 2019, SARS-CoV-2 has infected over 700 million people and caused > 7 million deaths. While much of the global north was severely affected, sub-Saharan Africa was relatively spared. Possible reasons include a younger population, fewer comorbidities, and pre-existing immunity. Here, we expand on previous work through a cohort of 306 subjects, with samples drawn pre-pandemic, intra-pandemic, and post-vaccination.

METHODS

We assessed antibody reactivity to seasonal coronaviruses, emerging coronaviruses, and SARS-CoV-2 spike (S), nucleoprotein (N), and receptor binding domain (RBD) proteins in a longitudinal cohort. Antibody neutralization was measured using a pseudovirus neutralization assay.

RESULTS

Our data show that 16%-20% of pre-pandemic samples had reactivity to SARS-CoV-2 N protein. Further, we noted relatively high reactivity to SARS-CoV-2 RBD (~31%), and low, but notable, seropositivity to SARS-CoV-2 S protein (3.3%-3.4%). We additionally found a significant jump in seropositivity to all SARS-CoV-2 proteins by March 2022 (intra-pandemic), and high levels of neutralization in the intra-pandemic samples compared to pre-pandemic samples. A boosting effect on SARS-CoV-2 Spike was observed after vaccination.

CONCLUSIONS

We report widespread circulation of SARS-CoV-2 in eastern Sierra Leone by March 2022 despite low national reporting. Furthermore, we provide evidence of pre-existing humoral immunity to SARS-CoV-2 as compared to US controls. This may have resulted in less severe disease, less COVID-19 testing and the apparent lack of clinical cases. Finally, we show boosting of SARS-CoV-2 Spike following vaccination. Studies comparing HLA type between symptomatic and asymptomatic cases are being planned. Studies to better characterize cellular immunity from pre-pandemic timepoints should also be prioritized.

Для цитирования: Samuels Robert J, Bond Nell G, Sumah Ibrahim, Grant Donald S, Kamara Mohamed S, Bazzano Lydia, Fernandez Camilo, Borrega Rodrigo, Chandra Sruti, Glezer Celia R, Schieffelin John S, Moon Troy D. Widespread SARS-CoV-2 Transmission Despite Limited Reported Cases and Clinical Disease: Exploring the Role of Pre-Existing Humoral Immunity to SARS-CoV-2 in Eastern Sierra Leone.. Immunity, inflammation and disease. 2026. DOI: 10.1002/iid3.70463.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.